By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TrovaGene today confirmed it has regained ownership of worldwide rights and control of its patent estate for transrenal technology for non-invasive prenatal applications and cancer after terminating a licensing deal with Sequenom.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.